Histotripsy at Hoag

Histotripsy for Liver Cancer

Advanced Treatment at Hoag

Histotripsy is a precise, non-invasive cancer treatment option and the only FDA-approved therapy of its kind for treating liver tumors. As one of only a few sites in the country to offer this revolutionary technology, Hoag is proud to provide patients access to the latest FDA-approved treatment options and therapies.

About Histotripsy

Histotripsy is a non-invasive, incisionless treatment that uses targeted ultrasound waves to wipe out cancer cells. The sound waves produce mini bubbles within the tumor, creating pressure to eradicate unhealthy cells, all while keeping surrounding liver structures and healthy tissue intact.

This FDA-approved treatment is performed by Hoag interventional radiologists and can coincide with chemotherapy and other treatment methods. Histotripsy has little to no side effects and patients usually go home the same day.

Histotripsy at Hoag
  • Futuristic Treatment

    Hoag is one of only two hospitals in the state of California and few in the nation to provide histotripsy – a futuristic treatment technology for combatting liver cancer and liver tumors.

  • Combined Expertise

    The combined expertise of Hoag Digestive Health Institute and Hoag Family Cancer Institute gives you access to the most advanced diagnostics, therapies and treatment options as well as groundbreaking clinical research.

  • Comprehensive Liver Care

    Hoag offers the leading comprehensive Liver Program in Orange County, ensuring seamless, coordinated care from diagnosis through treatment – so you can trust that you will have exceptional care.

Why Choose Hoag?
The Latest Diagnosis & Treatment Options

Our subspecialized team uses advanced diagnostics and therapies including interventional radiology. Hoag’s advanced imaging techniques, precise endoscopic diagnosis and staging, as well as noninvasive endoscopic treatment methods mean you receive the very best care.

Our Liver Program Team

Hoag Digestive Health Institute and Hoag Family Cancer Institute clinicians work together to provide liver cancer patients with the very latest treatment options, resulting in better outcomes.

Between our multidisciplinary group of fellowship-trained subspecialists in hepatology, liver surgery, endoscopy and diagnostic and interventional radiology and our care counselor and dietician, we help guide you through your entire care journey. Additionally, we conduct a Liver Case Conference where we discuss complex cases of liver cancer in a multidisciplinary fashion to foster collaboration to drive improved outcomes.

Meet the Interventional Radiologists
Alex Misono, M.D.
Dr. Misono specializes in Vascular and Interventional Radiology and has been with the team since 2018. An active researcher in the fields of radiology and interventional radiology, Dr. Misono graduated from Harvard Medical School and did his residency in diagnostic radiology at Massachusetts General Hospital and Harvard Medical School. Following that, he completed training as a fellow in Vascular & Interventional Radiology at the Miami Cardiac & Vascular Institute.
Trushar Patel, M.D.
Dr. Patel specializes in Vascular and Interventional Radiology with a focus in Interventional Oncology and has been with the team since 2014. After completing his residency at Cornell Medical Center and training at Memorial Sloan Kettering Cancer Center, Dr. Patel did a fellowship in Vascular and Interventional Radiology at the University of California, San Francisco.
Tust Techasith, M.D.
Dr. Techasith specializes in Vascular and Interventional Radiology, with a particular emphasis on minimally invasive treatment of cancer and venous disease, and has been with the team since 2020. After graduating from Harvard Medical School, he completed his internship at Santa Clara Valley Medical Center where he was awarded Intern of the Year. He subsequently completed both his residency training in Diagnostic Radiology, serving as chief resident, and fellowship training in Vascular and Interventional Radiology at Stanford University Medical Center.